FAQs



What does NeoStem do?

NeoStem is a biopharmaceutical company pursuing the preservation and enhancement of human health globally through the development of novel cell based individualized medicine therapeutics that prevent, treat or cure disease. The Company is developing therapies based on three platform technologies (immune-oncology, ischemic repair and immunomodulation) with a lead, late-stage clinical program for each. The combination of a rich therapeutics pipeline and an externally recognized in-house center for cell therapy process development and manufacturing has created an organization with unique capabilities for accelerated and efficient product development.

Back to Top


What is NeoStem’s relationship with Progenitor Cell Therapy, LLC?

Progenitor Cell Therapy, LLC (PCT) is a wholly-owned subsidiary of NeoStem, Inc. NeoStem acquired PCT in January, 2011.

Back to Top


What is NeoStem’s relationship with NeoStem Oncology, LLC?

NeoStem Oncology, LLC (formerly California Stem Cell, Inc.) was acquired by NeoStem, Inc. on May 8, 2014. It is  a wholly-owned subsidiary of NeoStem, Inc.

Back to Top


What is NeoStem’s relationship with Amorcyte, LLC?

Amorcyte, LLC is a wholly owned subsidiary of NeoStem, Inc.  NeoStem acquired Amorcyte in October, 2011.

Back to Top


What is NeoStem’s relationship with Athelos Corporation?

Athelos Corporation is owned by NeoStem with a minority interest by Becton Dickinson.

Back to Top


What is NeoStem’s Financial Conflict of Interest Policy?

You can view the Company’s Financial Conflict of Interest Policy by clicking here.

Back to Top


What is NeoStem’s ticker symbol, exchange and CUSIP?

The Company’s common stock is traded on NASDAQ, ticker symbol NBS . The CUSIP for the common stock is 640650404.

Back to Top


What is NeoStem’s fiscal year?

NeoStem’s fiscal year ends on December 31.

Back to Top


Who is NeoStem’s IR contact?

NeoStem, Inc.
Eric Powers
Phone: (212) 584-4173
E-mail: epowers@neostem.com

Back to Top


Who are NeoStem’s auditor and corporate legal counsel?

NeoStem’s auditor is Grant Thornton LLP. (www.granthornton.com)

NeoStem’s corporate legal counsel is Paul Hastings LLP. (www.paulhastings.com)

Back to Top


Who is NeoStem’s transfer agent?

NeoStem’s transfer agent is Continental Stock Transfer & Trust Company (www.continentalstock.com)

Back to Top